Mosman Oil and Gas (LON: MSMN) says the operator of the Vector helium project, where Mosman Oil and Gas has a 20% working interest, has signed a drilling contract to drill five wells. The purchase of an 82.5% stake in Sagebrush project should be completed by early February. The share price jumped 38% to 0.0345p. […]

The post AIM movers: Kromek signs deal with Siemens Healthcare and Futura Medical progress disappoints appeared first on UK Investor Magazine.

Video editing technology developer Blackbird (LON: BIRD) continues to rebound following the interims earlier in the week. The share price improved 22.7% to 6.75p. Revenues fell 30% to £692,000 because of the ending of the A+E deal and lower operating costs meant that the loss was reduced. Cash burn was similar at £1.9m, leaving net […]

The post AIM movers: Marlowe demerger and Fevertree Drinks hampered by weather appeared first on UK Investor Magazine.

Ondine Biomedical (LON: OBI) says nasal photodisinfection product Steriwave is now available through the NHS Supply Chain. This means that it will be easier for hospitals in England and Wales to buy the treatment. This follows initial use at Pontefract hospital. The share price improved 10% to 8.25p. Full year results from Pennant International (LON: […]

The post AIM movers: Ondine Biomedical NHS breakthrough and Getech continues to fall appeared first on UK Investor Magazine.

Mixer drinks supplier Fevertree Drinks (LON: FEVR) chairman Domenic De Lorenzo bought 45,000 shares at 973.8p each following the 2023 trading statement. This takes his stake to 49,500 shares. This comes after a tough period of trading in the past couple of years when revenues have continued to increase but margins have come under pressure, […]

The post Director deals: Should you follow Fevertree Drinks chairman? appeared first on UK Investor Magazine.

Fevertree Drinks (LON: FEVR) have trimmed rrofit forecasts, although Fevertree has reiterated its guidance of revenues between £390m and £405m. The AIM-quoted mixer drinks supplier has improved UK sales marginally, but that is on the back of a 5% price rise, so volumes have fallen. The share is still higher than in the first quarter […]

The post Fevertree sales build momentum appeared first on UK Investor Magazine.

Pathfinder Minerals (LON: PFP) has signed a conditional sale and purchase agreement with Acumen Advisory for the disposal of IM Minerals. This was originally announced earlier this year and the deal includes claims against the Mozambique government. The deal requires shareholder approval. There is an initial £2m payment and a contingent payment of the higher […]

The post AIM movers: Pathfinder Minerals finalises disposal and Anpario profit slump appeared first on UK Investor Magazine.

Slightly higher than expected 2022 revenues and profit were enough to push spectacles supplier Inspecs (LON: SPEC) was enough to push the share price 36.8% higher at 85.5p. The figures are still much worse than expected six months ago due to destocking and poorly performing businesses. Sales were flat at $246m, although there was growth […]

The post Inspecs sees improvement and ex-dividends appeared first on UK Investor Magazine.

Tungsten West (LON: TUN) has secured a term sheet for non-dilutive funding for the Hemerdon tungsten and tin mine in Devon and the final capital expenditure estimates are expected by the end of September. Royalty financing of $30m has been obtained at an initial rate of 4.75%, which drops to 2.375% after 7mmtu of tungsten […]

The post AIM movers: Tungsten West financing agreement and potential Transense licence appeared first on UK Investor Magazine.

CMO Group (LON: CMO) fell 54.8% to 35p, making it the worst performer of the week. Last year’s placing price was 132p. The online retailer of building products says revenues in the 27 weeks to June 2022 are 10% ahead, or 2% higher like-for-like. Full year guidance is that 2022 revenues will increase from £76.3m […]

The post AIM weekly movers: CMO Group shares fall by nearly three-quarters from float price appeared first on UK Investor Magazine.

Fevertree shares tumbled 26.3% to 883p in early afternoon trading on Friday after the drinks company announced a revised FY 2023 EBITDA between £37.5 to £45 million, down from £63 million to £66 million. The drinks producer reported a significant worsening of cost headwinds in the last few months, predominantly linked to freight and glass […]

The post Fevertree shares tumble 26% after company downgrades annual EBITDA guidance appeared first on UK Investor Magazine.

Fevertree Drinks (LON: FEVR) was already one of the worst performing large AIM companies this year before the latest 27.6% sump to 867.75p. The share price has fallen by two-thirds during 2022 and, because of its size, this is one of the major reasons why AIM has underperformed so hugely this year. The mixer drinks […]

The post AIM movers: Fevertree Drinks goes flat and Ncondezi Energy feasibility study for solar power plant appeared first on UK Investor Magazine.

Producer of premium drink mixers Fevertree Drinks PLC (AIM:FEVR) saw its shares dip marginally during Tuesday trading, with the impression left by its first-half performance being more sour than sweet. Overall, the company booked an 11% year-on-year decline in first half revenues, down to £104.2 million. Proportionally, its largest fall was suffered in Europe, with […]

The post Fevertree shares dip as sunken profits leave a bitter taste appeared first on UK Investor Magazine.